Forest Investigative Site 1392 — Yukon, Oklahoma

Forest Investigative Site 1392 is a clinical research site located in Yukon, Oklahoma, United States 73099.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1392 has participated in 1 clinical trials.

Therapeutic areas: Stage 1 Hypertension, Stage 2 Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Yukon

Browse all research sites in Oklahoma · View every site in Yukon

• Integris Yukon Hospital
• Tekton Research
• Integris Family Care Yukon
• Research Site
• Tekton Research, Inc - Yukon Location
• Ironwood Investigational Site
• GSK Investigational Site
• Pfizer Investigational Site
• Tekton Research- Yukon
• Tekton Research - Oklahoma - Primary Health Partners
• Aquilo Research
• Santarus Clinical Investigational Site 5001

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1392?

Forest Investigative Site 1392 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1392 conducted?

Forest Investigative Site 1392 has 1 clinical trials on record. Their work covers Stage 1 Hypertension, Stage 2 Hypertension.

Is Forest Investigative Site 1392 accredited by Crixeo Clinical Trials?

Forest Investigative Site 1392 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1392?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.